According to the Zhitong Finance App, the Emmy Vaccine (06660.HK) announced that the highly cost-effective human diploid rabies vaccine developed independently by the company has recently submitted an application for marketing registration to the State Drug Administration.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.